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Abstract
Background
Adherence to treatment is a crucial factor for patients who have chronic illnesses or multiple
morbidities and polypharmacy, which is frequently found in older adults. The non-adherence
to medications has important economic and social consequences as well as impacts on the
health of the patients. One of the reasons that can explain the low adherence to treatment,
is the memory deficits that are characteristics of this population and that are even more evi-
dent in cases that involve neurodegenerative diseases.
Methods and findings
In this study, we explore whether the differential outcomes procedure (DOP), which has
been shown to be useful in improving discriminative learning and memory in different popu-
lations, may facilitate learning and retention of medical recommendations in older adults
who have been diagnosed with Alzheimer’s disease. The results demonstrate that when this
procedure was applied, the patients showed improvements in learning and long-term reten-
tion of two pill/time of day associations in a situation that simulates adherence to medical
prescriptions.
Conclusions
These findings contribute new data about the potential benefits of the DOP in patients with
neurodegenerative disorders, highlighting the important role that this procedure could play
in addressing important issues related to the health and quality of life of older adults, with or
without neurodegenerative diseases, such as low adherence to medical treatments.
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Introduction
It is well known that medicine has grown exponentially over recent decades. The advances in
the different disciplines that converge within medicine have not only made it possible to have
timely and precise diagnoses of different pathologies but also resulted in the development of
treatments for practically all diseases or, failing this, the possibility of treating symptoms,
boosting the quality of life of those who are afflicted by these diseases. However, we are faced
with a challenge that for many years has attracted the attention of governments, public health
institutions, and international organizations that have expressed their concerns over patients’
lack of adherence to medical treatment [1].
In 2003, the World Health Organization [2] defined adherence to treatment as the degree
to which the drug-taking behavior, follow through on a diet, or modification of living habits of
a patient corresponds to the recommendations of healthcare professionals. In that report, it is
also indicated that approximately 50% of patients have difficulties in following their medical
prescriptions (they do not take the medication as it has been prescribed), which lead to unnec-
essary prolongation of diseases or to death. It is worth noting that non-adherence to medical
prescriptions still remains as a critical public health issue [3]. In fact, different studies have
observed a direct relationship between the lack of adherence to treatment of patients and the
increment in the budget of local public health systems [1,4–6]. Furthermore, Silva, Galeano,
and Correa [7] indicate that adherence-to-treatment issues are present in all types of patholo-
gies, among all age groups, in different life stages, and, in particular, in patients who have
chronic treatments, which affect an important part of the population.
Some authors have noted that ageing is one of the most important factors related to adher-
ence to treatment shown by patients (e.g., [8,9]). Thus, Leal, Abellán, Casa, and Martı́nez [10]
observed that adherence to medication decreases as the number of pills that patients must take
every day increases, mainly for patients older than 65 years with chronic illnesses. In other
words, the greater the number of medications is, the lower the percentage of fulfilling the med-
ical recommendations will be. Specifically, it is expected that 75% of people older than 65 years
will correctly follow the treatment when they must take one pill; 68% when the medical pre-
scription is two; 54% when three pills are prescribed; and 35% when the doctor prescribed
four pills. This trend continues to progressively decrease until it reaches 10% adherence for
those who must take nine medications a day [10]. This polymedication condition, that involves
the management of complex medication regimens, places an excessive burden on memory,
highlighting one of the most frequent issues associated with age-related cognitive deteriora-
tion, a deficit in working memory capacity (e.g., [11,12]). In fact, it is known that approxi-
mately 80% of the information provided by doctors to patients will be forgotten immediately
or remembered incorrectly, particularly when they are older or they are anxious, making
patients’ forgetfulness of taking their prescribed medication one of the main issues for adher-
ence to treatment [13,14]. Note that explicit memory deficits of prescribed information dra-
matically increase when patients present any neurodegenerative disease, especially when
dementia is involved [15], or multiple morbidities that require several medications daily.
These conditions increase the burden on mnemonic resources, which could explain the low
treatment adherence rate that characterizes this population (e.g., [16]). In accordance with
this, it has been found that the higher the memory scores from the memory subscale of the
Dementia Rating Scale (DRS, [17]), the better the adherence to treatment observed in older
adults with cognitive impairment [18]. Considering the important economic and health conse-
quences of low adherence to medical prescriptions, developing new proposals that facilitate
adherence to medical treatment, particularly in cases of older adults who have multiple chronic
diseases, would be very welcome. Such kinds of proposals should be designed to foster memory
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of medical prescriptions and the active participation of the patients, for instance, through the
use of mnemonic techniques that may facilitate learning schedules, the dosage, or the identifi-
cation of medicines. In the present study, we aim to assess the benefits of one of these tech-
niques, known as the differential outcomes procedure ([19]), in the context of adherence to
treatment in dementia.
The use of outcomes-based procedures stems from the animal experimental tradition in
which the outcomes (reinforcers) after correct responses are administered to improve discrim-
ination learning. In discrimination learning, the participant (animal or human) is presented
with a set of stimuli (for instance, a plate with soup or a plate with pasta), which are referred to
as the sample stimuli. Then, a set of choices is displayed (for instance, a spoon and a fork),
which are referred to as the comparison stimuli. Participants have to learn, in a trail-by-error
manner, which sample stimulus goes with each comparison stimulus. A delayed-matching-to-
sample task is used if there is a temporal interval between the presentation of one of the sample
stimuli and the presentation of the comparison stimuli (choices) in each trial. When the choice
(response) is correct, an outcome (reinforcer) comes up to provide the participant with feed-
back about the correctness of its/his/her responses. Usually, all outcomes are provided inter-
changeably in a random manner when the more standard non-differential outcomes
procedure (hereafter the NOP) is used. However, what characterizes the differential outcomes
procedure (hereafter the DOP) is that each outcome is unique to each sample stimulus-com-
parison stimulus association. For instance, in the presence of a plate of soup, choosing the
spoon may always be reinforced with the outcome “well done”, whereas in the presence of a
plate of pasta, choosing the fork may always be reinforced with the outcome “correct” (see Fig
1A for an illustration of the two outcomes procedures). The DOP has proven its effectiveness
in improving discriminative learning in animals (see [20], for a review), children (e.g., [21]),
university students (e.g., [22]), and patients (e.g., Down syndrome, [23]), and recent studies
have extended its application to populations with recognition memory deficits (for a system-
atic review, see [24]).
In terms of the therapeutic utility of the DOP, recent research has addressed daily deficits
shown by patients with memory recognition deficits. For instance, Hochhalter, Sweeney,
Bakke, Holub, and Overmier [25] found that four patients with alcohol dementia, who often
had difficulties with delayed facial recognition, improved recognition of familiar faces when
each face was associated to a specific outcome (DOP) in comparison to when outcomes were
randomly administered (NOP). An advantage of the DOP compared to the NOP was also
observed by López-Crespo, Plaza, Fuentes, and Estévez [26] with older adults who displayed
the typical memory deterioration associated with ageing. Also, Plaza, López-Crespo, Antúnez,
Fuentes, and Estévez [27] carried out a study with eight older adults with Alzheimer’s disease
(AD) to assess whether the use of the DOP would have an impact on recognition memory per-
formance in these patients, promoting some improvement in delayed facial recognition. The
results indicated that patients with AD had a higher accuracy in the memory tests when the
outcomes (photographs of an umbrella, a scarf, a perfume bottle, and a mug, which were raf-
fled off at the end of the study), were administered in a differential manner (the DOP), in com-
parison to when the outcomes were administered in a random manner (the NOP). These
findings demonstrated, for the first time, that patients with this type of dementia could benefit
from the application of such a simple training procedure to ameliorate their deficits in recogni-
tion memory. Similar results have been found in two recent studies indicating the effectiveness
of the DOP in improving visual recognition memory for non-facial visual stimuli [28] as well
as spatial working memory [29] in this population.
Of special interest for the objectives of the present research is the study of Molina, Plaza,
Fuentes, and Estévez [30] with healthy young adults. The authors used a great number of
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illness-treatment pairings to simulate daily conditions of many older adults, with or without
age-relate neurodegenerative diseases, who have to learn which medicines are appropriate for
their multiple diseases. The results indicated that, compared to the standard or non-differential
outcomes procedure (the NOP), when each to-be-learned association was reinforced with a
unique outcome (the DOP), participants showed higher percentage of correct responses,
needed fewer trials to learn the associations, and demonstrated greater long-term retention of
the information that was previously learned. In a recent follow-up study, Plaza, Molina, Fuen-
tes, and Estévez [31] demonstrated that healthy older adults also benefited from the DOP
when the to-be-learned association was between a particular pill and the time of the day the
participants had to take it according to a prescribed schedule. The benefits of the DOP
extended also to performance in a recognition memory test that took place one week later. The
results showed the expected greater learning and long-term retention when the DOP was used
compared to the NOP. These findings suggest that the DOP could be deemed as an appropri-
ate complementary strategy in intervention programs that aim to increase adherence to medi-
cal treatments, particularly in people with learning and memory deficits that have serious
impact on their everyday lives.
In the present study, we sought to assess the benefits of the DOP in patients who have been
diagnosed with AD, in conditions that simulate adherence to medical treatment. Concretely,
we asked whether the implementation of the DOP with these patients would benefit their abil-
ity to learn and remember the time-based schedule of the medication administration as might
had been prescribed by a doctor, which could have a beneficial impact on their adherence to
treatment and therefore on their health. To that end, we used a task that simulated the adher-
ence to a new pharmaceutical treatment in which patients had to learn to associate two
Fig 1. A) Illustration of both differential (above) and non-differential (below) outcomes procedures. B) Stimulus sequence (from left to right) used in the learning task.
S = sample stimulus; C = comparison stimulus or choice; O = outcome.
https://doi.org/10.1371/journal.pone.0231578.g001
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medicines (two pills) with the time of day (morning and night) they should be taken (see [31]).
Outcomes consisted of two reinforcers (e.g., a pair of gloves and a keychain) that could be
administered under the DOP (a unique outcome followed each determined pill/time of day
association) or under the NOP (each outcome could be administered after each pill/time of the
day association in a random manner). A repeated measures design was employed in this study.
Consequently, all participants carried out the learning task and the memory tests under both
outcomes conditions in a counterbalanced way. Memory tests were conducted 1 hour and 1
week after the learning training sessions. On the basis of the results observed by Molina et al.
[30] and Plaza et al. [31], as well as those of other studies that have shown long-term memory
improvements under the DOP (e.g., [28,32,33]), we hypothesized that patients with AD will
show improved learning and long-term retention of the learned associations when they are
trained with the DOP compared to when they are trained with the NOP.
Method
Participants
Twenty-two participants, eleven healthy controls (HC) and eleven patients with Alzheimer’s
disease, participated in the study. A priori power analysis was performed with the G�Power
software 3.1.9.2 [34] in order to determine the minimum required sample size to detect main
effects and interactions. With an alpha = .05 and power = .80, the analysis showed that twelve
participants were required to detect a medium effect size (d = 0.64) according to previous stud-
ies that used the DOP with AD patients [27–29].
AD patients were recruited from Virgen de la Esperanza and La Purı́sima senior assisted
living homes (Almerı́a, Spain). An experienced neurologist established the diagnosis on the
basis of the National Institute of Neurological and Communicative Disorders and Stroke
(NINCDS), and Alzheimer’s Disease and Related Disorders Association (ADRDA) criteria for
probable Alzheimer’s disease [35,36]. Only patients in phase 4 of the Reisberg’s global deterio-
ration scale [37] participated in the study. They also had a relatively low MMSE score indicat-
ing moderate cognitive impairment (mean MMSE = 19.6). Exclusion criteria included (i) any
neurological disease other than AD such as frontal lobe dementia, vascular dementia, alcohol
dementia, Lewy body dementia, normal pressure hydrocephalus, brain tumor, Parkinson’s dis-
ease, or Huntington’s disease, and (ii) health conditions or medications that prevented patients
from joining the study. The HC participants were recruited from the community and were
free from serious medical conditions (i.e., heart disease, cancer, neurological disease including
dementia, psychiatric illness, substance abuse disorder, or substance dependence). They all
scored above 24 in the MMSE. Table 1 shows demographic and clinical information for partic-
ipants of the two groups (AD and HC). This study was approved by the University of Almerı́a
Bioethics Committee in Human Research, and it was conducted according to the ethical proto-
cols and recommendations of the ‘Code of Good Practices in Research’ of this committee and
to the principles expressed in the Declaration of Helsinki. Informed written consent was
obtained from all participants or patient’s caregiver. Finally, two AD patients and one partici-
pant from the HC group did not complete the training (they all missed one session), and con-
sequently the final sample included 10 HC participants and 9 AD patients.
Stimuli and materials
The sample stimuli consisted of two sets of pictures of two different pills (set one: a yellow pill
and a pink pill; set two: a blue and pink pill and a blue and red pill). The comparison (choice)
stimuli consisted of two pictures representing two times of day (morning and night). The out-
comes (reinforcers) consisted of two sets of pictures representing the gifts that the participants
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could receive at the end of the study an served to provide feedback about whether the response
(choice) was correct or not (set one: a pair of gloves and a keychain; set two: a pair of socks
and a mug). All stimuli were displayed covering an area of 5.5 X 6.5 cm. E-Prime 2.0 software
[38] controlled stimulus presentation as well as participants’ responses (accuracy and latency
data). All stimuli were presented with a white background on a color touch TFT-LCD com-
puter screen. The reinforcers were raffled off at the end of the experiment. All participants
received one of them and an acknowledgment diploma for their participation.
Procedure
All participants were tested individually in a quiet room. We used a delayed-matching-to-sam-
ple task that consisted of two phases (1 and 2), separated by one week. Each phase consisted of
a pre-training session followed one day later by training session 1 and then two days later by
training session 2 (see Fig 2). Each training session lasted approximately 30 minutes. At the
beginning of each session, participants were instructed that the task required to guess first, and
remember later on, which time of day was associated with the pill they had just been presented
with, according to the supposed medical treatment prescribed by a doctor. Instructions were
verbally given by the experimenter while a sample trial was shown on the screen. Then, they
performed one practice trial (pre-training session) or four practice trials (training sessions)
Table 1. Demographics and clinical information for the HC and AD groups. Mean scores and standard deviations (in parentheses) are shown.
Socio-demographic data and tests Maximum HC AD
n 10 9
Sex (F/M) 6/4 6/3
Age 74(10.3) 73.7(9.6)
MMSE�� 30 28.7(1.6) 19.6(4.7)
GDS�� 7 1.5(0.5) 4(0)
CERAD Battery
Boston Naming Test�� 15 14.4(1.1) 6.7(3)
Word List Memory�� 10 6.3(2.3) 2.2(1.8)
Word List Recall�� 10 5.5(2.8) 0.9(0.8)
Word List Recognition�� 20 17.3(4.5) 9.4(5.8)
Constructional Praxis�� 11 9.1(3.5) 0(0)
Trail Making Test (part A)�� 61.3(43.4) 136(18.5)
Trail Making Test (errors)�� 0(0) 1.3(1.1)
Barcelona Test (Subtests)
Constructive Praxis to the Copy�� 18 17.1(1.5) 4.7(3.3)
Semantic Fluency�� 18.5(5.3) 8.7(3.1)
Phonological Fluency (P) �� 19.7(10.3) 6.9(3.2)
Forward Digits Span 9 5.5(1.4) 4.1(1.1)
Backward Digits Span�� 8 3.3(0.8) 1.7(1.1)
Abstraction�� 12 9.4(3.1) 3.4(2.1)
Reciprocal Coordination�� 14(2.1) 1.9(1.2)
Beats count 8.2(4.2) 9(5.8)
MMSE = Mini-Mental State Examination; GDS = Global Deterioration Scale; CERAD = The Consortium to Establish a Registry for Alzheimer’s disease; HC = healthy
controls; AD = Alzheimer’s disease.
��p<0.01
https://doi.org/10.1371/journal.pone.0231578.t001
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before completing 36 training trials grouped in three blocks of 12 trials each. The order of the
blocks was counterbalanced across participants.
Each trial began with a central fixation point (#) during 1000 ms followed by a blank screen
for 500 ms. Then, one of the sample stimuli (the picture of a pill) appeared in the middle of the
screen for 3000 ms. After a 500 ms delay interval with a blank screen, the two comparison sti-
muli (the morning and night pictures) were presented until the participants responded. Partic-
ipants were asked to touch the picture of the time of day that was associated with the sample
pill they had just been presented with. Responses were followed by either the picture of a rein-
forcer (the outcome) when they were correct, or a blank screen when they were incorrect, in
both cases during 2500 ms. Then, the experimenter pressed the space bar and the next trial
began. Fig 1B illustrates the sequence of events of one trial.
As mentioned above, the pre-training session was administered to all participants to ensure
that they understood the task demands before the two training sessions started. At the begin-
ning of phase 1 session, and before the training sessions started, participants were randomly
assigned to one of the two outcomes conditions, differential (DOP) or non-differential (NOP),
Fig 2. Sequential progression (from left to right) of the two phases of the study. The memory task was performed one hour after each of the two training sessions
and a week after the last training session of each phase (see Fig 2). The memory task consisted of two trials, one with each trained pill-time of day association, identical to
that used during the training sessions except that outcomes were not administered at all. That is, as it is depicted in Fig 1B, participants first saw the picture of a pill and,
after a short delay (500 ms), they had to choose, by touching the screen, the picture of the time of day associated with the pill. After a response was made, the screen
remained blank for 2500 ms, and then the next trial began.
https://doi.org/10.1371/journal.pone.0231578.g002
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according to a computer-generated blocked randomization schedule. Participants that during
phase 1 were assigned to the DOP, during phase 2 performed the training sessions under the
NOP, and vice versa. Under the DOP, each pill/time of day association was consistently rein-
forced with a determined outcome when the participant’s choice was correct (yellow pill/
morning association could be reinforced with the outcome “a pair of gloves”, whereas pink
pill/night association could be reinforced with the outcome “a keychain”). Under the NOP,
each pill/time of day association was reinforced with one of the outcomes in each trial, so that
the two outcomes followed each pill/time of day association an equal number of times across
the training session. A week later, participants were trained with the same task during another
three sessions (phase 2) but using the other set of two pill-time of day associations (e.g., the
blue and pink pill/morning and the blue and red pill/night associations) under the opposite
outcomes procedure condition.
Statistical analysis
Percentages of correct responses for each participant were grouped in three blocks of 12 trials
in each training session. Sex did not produce any statistically significant effect nor interacted
with any other factor, and consequently data from women and men were collapsed. Data were
submitted to a mixed ANOVA with Group (AD and HC) as the between-participants factor
and Outcomes (DOP and NOP), Training Session (1 and 2) and Blocks (B1, B2 and B3) as the
within-participants factors. Latency data did not show any significant effect and therefore are
not reported.
Because the pattern of results was similar for the memory task performed one hour after
each of the two training sessions (a short retention interval), data from these two memory
tasks were also collapsed for the statistical analyses. Percentages of correct responses from the
short- (one hour) and long-term (a week) memory tests were finally submitted to a mixed
ANOVA, with Group (AD and HC) as the between-participants factor and Outcomes (DOP
and NOP) and Retention interval (short and long) as the within-participants factors. One AD
patient and one HC participant did not complete one of the tests in one of the Outcomes con-
ditions–DOP or NOP–so their data were excluded from the memory tests analysis. The statis-
tical significance level was set at p� .05.
Results
Training sessions
Results from the accuracy data analysis showed significant main effects of Outcomes [F(1,17)
= 8.79, p = 0.009, ηp2 = 0.341] and Group [F(1,17) = 26.93, p< 0.001, ηp2 = 0.613]. Healthy
controls were more accurate than the patients (91% vs. 57% correct, respectively); and partici-
pants performed the task better in the DOP than in the NOP condition (78% vs. 69% correct,
respectively). The two-ways Outcomes X Group interaction was significant [F(1,17) = 5.60,
p = 0.030, ηp2 = 0.248]. The interaction showed that the DOP produced significantly higher
accuracy than the NOP just in the AD group [F(1,8) = 6.91, p = 0.030, ηp2 = 0.463], but not in
the HC group [F(1,9) = 1.26, p = 0.290, ηp2 = 0.123]. Importantly, the Outcomes X Training
Session X Group interaction was also significant [F(1,17) = 9.05, p = 0.008, ηp2 = 0.347]. The
three-ways interaction analyses revealed that the Outcomes X Training Session partial interac-
tion was significant just for the AD group [F(1,8) = 17.90, p = 0.003, ηp2 = 0.691], but not for
the HC group [F(1,9) = 0.74, p = 0.412, ηp2 = 0.076]. Whereas performance in the DOP and
the NOP was equivalent across the two sessions in the HC group, in the AD group an Out-
comes effect was observed in the second session [F(1,8) = 10.53, p = 0.012, ηp2 = 0.568]. That
is, the beneficial effect of the DOP in AD patients’ discriminative learning was evident only in
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the last training session (70% vs. 47% correct for DOP and NOP, respectively). To further
explore this learning effect, the six blocks of trials (three from each session) were analyzed for
each group in each Outcomes condition separately. It is worth noting that only in the DOP
condition patients’ performance showed a significant learning curve [Blocks effect: F(5,40) =
4.03, p = 0.005, ηp2 = 0.335]. As it can be observed in Fig 3, AD patients did not learn the task
when trained with the NOP (their performance was at chance in all blocks).
Memory tests
Fig 4 shows the percentage of correct responses in the memory tests. The results revealed sig-
nificant main effects of Group [F(1,15) = 40.24, p< 0.001, ηp2 = 0.728] and Outcomes [F(1,15)
= 6.91, p = 0.019, ηp2 = 0.315]. The AD patients’ performance in the memory tests was lower
than that of the HC participants (63% vs. 97% correct), and participants showed an overall bet-
ter retention of the learned associations when they were trained with the DOP (84% correct)
than when they were trained with the NOP (76% correct). The two-ways Outcomes X Group
interaction reached statistical significance [F(1,15) = 6.91, p = 0.019, ηp2 = 0.315]. The analysis
of the interaction revealed a significant effect of Outcomes in the AD group [F(1,7) = 6.89,
p = 0.034, ηp2 = 0.496] but not in the HC group [F(1,8) = 0.00, p = 1.000, ηp2 = 0.000]. That is,
only AD patients showed an improvement in memory performance when the DOP and the
NOP conditions were compared (71% vs. 54%, respectively), being their performance at the
chance level just in the NOP condition.
General discussion
It is expected that a pharmaceutical treatment will meet its goal when there is at least an 80%
adherence to treatment (e.g., [1,39]). Nevertheless, this percentage could be impacted by sev-
eral variables such as the severity of the disease, cognitive deterioration, age, errors in dosage,
forgetting to take medications, or mistaking medications, which impact not only the fulfill-
ment of medical advice but also the quality of life of the patients (e.g., [40,41]). Consequently,
the development of new therapeutic strategies that may facilitate adherence to treatment, par-
ticularly in the more advanced stages of life when cognitive problems (e.g., memory loss) and
health issues increase, should be deemed of crucial relevance. The present study was conducted
with the main aim of assessing whether one of these possible strategies based on learning
through differential outcomes, would facilitate the learning and retention of medical prescrip-
tions in adults diagnosed with AD, in a simulated medical treatment context. Accordingly, our
AD patients learned the pill/time of day association task when they were trained under the
DOP, but not when they were trained under the NOP, performance being at chance level just
in the latter condition. A detailed inspection to the present findings in comparison with those
of previous related studies suggest that the amount of training is an important factor for the
benefits of the DOP to be observed with these kinds of patients. For instance, whereas Plaza
et al. [31] observed DOP benefits when healthy older adults received just one single training
session, in a task similar to the one employed in the present study, AD patients in the Vivas
et al. [29] study showed moderate improvements in spatial recognition memory with just one
training session, and benefits restricted just to the last block of trials. It led us to increase the
number of training trials here, as we anticipated that our AD patients would exhibit greater
difficulty in learning/remembering the pill/time of day associations, compared with healthy
adult participants. Note also that it is likely that learning tasks like the one used in the present
study require the activation of two processes that were deteriorated in the AD population: dis-
crimination learning, involved in the establishment of the pill-time of day associations, and
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short-term memory, given that a delay of 500 ms was interposed between both types of stimuli,
sample stimuli and comparison (choice) stimuli.
Regarding long-term memory of the learned associations, we also found an overall advan-
tage when the DOP methodology was used during the training sessions. The effect was particu-
larly important for patients with AD who, again, showed a performance close to chance with
the NOP (54% correct), which increased considerably when they were trained with the DOP
(71% correct). These results are relevant because, for the first time, reveal an improvement in
long-term retention of information previously learned by using the DOP, in people who have
been diagnosed with a neurodegenerative disease usually associated with learning and memory
deficits (e.g., [42]). This finding adds to that reported by Carmona et al. [28] using a visual rec-
ognition task. Specifically, the memory decline (less hits, more false alarms, and a lower
discriminability) that was observed in eight AD patients at the 1-week memory test, was not
found when the patients were trained with the DOP. Taken together, the results from both
studies highlight the potential of the DOP to improve long-term retention in people with
memory impairments.
Finally, in contrast to what Plaza et al. [31] observed with older adults, the results of our
control group (healthy older adults) did not reveal significant differences irrespective of the
learning outcomes condition to which the participants were assigned. In other words, their
performance oscillated between 90% and 100% accuracy, regardless of how the reinforcers
Fig 3. Mean percentages of correct responses obtained by participants in the discriminative leaning task as a function of the training session (1 and 2),
blocks of trials (three blocks of 12 trials each), outcomes (DOP and NOP) and group (patients with Alzheimer’s disease–AD- and healthy controls–HC-
). Error bars show the standard error of the mean.
https://doi.org/10.1371/journal.pone.0231578.g003
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were administered after their correct responses. These results suggest a ceiling effect in this
group of participants who found the task very easy to learn. In fact, previous studies have
shown that when the difficulty of the task is low, the DOP does not produce any benefit or
improvement in either latency or accuracy data (e.g., [21,22,43]). However, it should be noted
that when the demands of the task increased (by increasing, for example, the number of pill/
time of day associations to three, see [31]), the use of the DOP positively affected both discrim-
inative learning and long-term retention of information in older adults without cognitive
impairments. Therefore, taken together, all these studies suggest that learning under the DOP
can be deemed as a useful and complementary strategy to increase adherence to treatment in
normal and pathological aging.
A final question refers to the mechanisms by which the DOP exerts its beneficial effects on
performance. The two-memory systems model [44], an evolution of the Expectancy Theory
[45], is currently the most comprehensive account of how the DOP works. In short, primarily
based on studies conducted with animals, Savage and colleagues (e.g., [46–49]) suggested the
existence of two well-differentiated neurochemical and neuroanatomical systems that become
activated independently, depending on how the reinforcers are administered, either differen-
tially as in the DOP, or non-differentially as in the NOP. Specifically, when the outcomes are
presented randomly, or non-differentially, the explicit retrospective memory system is acti-
vated. This system is dependent on the cholinergic system and is linked to the normal func-
tioning of the hippocampus. On the other hand, when the administration of outcomes is
specific, as in the DOP, an implicit prospective memory system is activated, a type of memory
related to the glutamatergic system that involves the basolateral amygdala in animals (see [49],
for a review). Prospective memory of the unique outcome associated with each sample stimu-
lus would guide the selection of the appropriate choice. Thus, the selection of the correct
Fig 4. Mean percentages of correct responses obtained by participants in the memory tests as a function of retention interval (short and long), outcomes (DOP
and NOP) and group (patients with Alzheimer’s disease–AD- and healthy controls–HC–). Error bars show the standard error of the mean.
https://doi.org/10.1371/journal.pone.0231578.g004
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comparison stimulus will not depend exclusively on the explicit retrospective recall of the sam-
ple stimulus.
Several studies conducted with humans have supported this model, particularly the study
by Mok, Thomas, Lungu and Overmier [50], who investigated the brain structures that are
linked to the functioning of the DOP in humans. In this study, brain activity was explored
through functional magnetic resonance imaging (fMRI) while the participants performed a
discriminative learning task that was reinforced under the DOP or the NOP, with auditory (a
non-vocal initial excerpt from the pop song Macarena), or visual (three smiling baby pictures
presented successively) outcomes. Mok et al. [50] found that activation of the hippocampus
increased during the delay interval between the sample stimulus and the comparison stimuli
when the participants were performing the task under the NOP, which indicate that this struc-
ture is involved in the retrospective processing of information in humans too. However, unlike
the results obtained with animals, when the participants were trained with the DOP, increased
activation was observed in brain areas related to the sensory nature of the outcomes. Thus,
when the discriminative stimulus was associated to a visual outcome (smiling baby pictures),
the areas involved in the processing of visual information (i.e., Brodmann areas 18 and 19)
were activated during the delay. On the other hand, when the associated outcome was an audi-
tory stimulus (a non-vocal excerpt from the song Macarena), the areas involved in the process-
ing of this type of information (i.e., Brodmann areas 41 and 22) were activated. Furthermore,
in both cases, the activation of the angular gyrus of the posterior parietal cortex was observed,
indicating its involvement in prospective memory. A recent study has also demonstrated that,
as the two-memory system model suggests, this prospective memory is largely implicit [51]. In
fact, participants showed a better visual recognition memory when the DOP was applied
regardless of whether the outcomes or the sample stimuli were presented under subliminal
(non-conscious) or supraliminal (conscious) conditions.
Limitations and conclusions
A first limitation of the present study is the small sample of participants in both groups.
Although further studies with ample samples are always an important research goal, it is worth
noting that we have observed a clear-cut pattern of results that systematically replicates a main
finding: the benefit of using differential outcomes when people with or without neuropathol-
ogy have to learn and retain in memory determined stimulus-response associations. A second
limitation of the study is that the task might have been very easy for the control group, who
learned it without great effort, showing ceiling effects. However, the main aim of this particular
study was not to explore DOP benefits in our adherence to treatment simulation in the elderly,
but whether such procedure may be of any help to ameliorate the learning/memory deficits in
AD patients, with a task that is appropriate to this kind of population. A third limitation is that
sociodemographic as well as affective states of the participants may play a role in the efficiency
with which people perform learning and memory tasks. Further research should explore how
these factors interact with the learning procedure to determine how well patients adhere to
medical prescriptions.
To sum up, the results obtained in the present study, along with those from previous studies
[25,27–29] suggest that the use of the DOP could be very useful in training patients with learn-
ing and memory deficits that result from damage to the hippocampus or the dopamine system.
Such is the case of the target population of this study, older adults who have been diagnosed
with AD. Importantly, our findings indicate also that this procedure could be integrated into
more comprehensive training programs with the goal of improving the well-being and the
quality of life of these patients as well as of older adults with or without neurodegenerative
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disorders. One example of this sort of programs is the promotion of adherence-to-treatment
behavior through the learning and retention of the drugs patients must take at specific times
throughout the day. Finally, it is worth noting that the DOP is an inexpensive method that sim-
ply consists in consistently associate each correct stimulus-choice sequence with a unique out-
come (for example, a specific reinforcer). It makes the procedure easy to be implemented not
only by healthcare professionals but also by family members or caretakers, which widens its
scope of action and increases the possible benefits that this procedure may have for the physi-
cal and psychological health of different populations.
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